Table 1.
Baseline demographic, clinical, and MRI data of patients with TM
| Variable | Value |
|---|---|
| Age (y) | 37.12 ± 10.68 |
| Females, N (%) | 150 (50.8) |
| Regular transfusion starting age (mo) | 16.86 ± 22.78 |
| Chelation starting age (y) | 4.55 ± 3.65 |
| Splenectomy, N (%) | 172 (58.3) |
| Pre-transfusion hemoglobin (g/dL) | 9.61 ± 0.45 |
| Mean Ferritin (ng/mL) | 780.07 ± 792.04 |
| MRI LIC (mg/g dw) | 5.26 ± 8.05 |
| MRI LIC > 3 mg/g dw, N (%) | 118 (40.0) |
| Global pancreas T2∗ (ms) | 13.47 ± 10.69 |
| Global pancreas T2∗ < 26 ms, N (%) | 251 (85.1%) |
| Glucose metabolism, N (%) | |
| Normal | 186 (63.1) |
| Impaired fasting glucose | 17 (5.8) |
| Impaired glucose tolerance | 40 (13.6) |
| Diabetes mellitus | 52 (17.6) |
ms, milliseconds; N, number.